Clinical trial Recruiting at 1 site Interventional Ages 12 Months to 10

Manual Therapy Before Neuromotor Rehab in Children with Cerebral Palsy

Official title: Short-Term Effects of Lower Limb Manual Therapy as a Preparatory Phase for Neuromotor Functional Therapy in Children With Spastic Cerebral Palsy: A Prospective Self-Controlled Pilot Study

Run by LIFE - Research and Care Institute - Santa Lucia IRCCS · NCT07902466 · Data updated 2026-11-12

In this pilot study, researchers test whether 30 minutes of lower-limb manual therapy before functional neuromotor therapy helps improve gait and motor performance in children with spastic cerebral palsy.

More Cerebral Palsy (CP) trials

Quick facts

Study typeInterventional
Ages12 Months to 10 Years
SexAll
Enrollment20 (estimated)
SponsorLIFE - Research and Care Institute - Santa Lucia IRCCS
Academic / other
Locations1 site (Roma, Roma)
StatusRecruiting
StartedOctober 15, 2026
Main results expectedDecember 2026
Study endsMarch 2027
Registry record updatedOctober 28, 2026
Trial IDNCT07902466 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children ages 1–10 with spastic CP (hemiplegia or diplegia), GMFCS I–IV, and MAS ≤ 3 in the lower limbs.

Probably not a fit

Children with more severe spasticity, recent lower-limb procedures, or cognitive barriers preventing task participation may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This monocentric pilot study enrolls 20 children with spastic CP (hemiplegic or diplegic) aged 1–10 years to see if a preparatory 30-minute lower-limb manual therapy session can immediately enhance gait and neuromuscular function when followed by functional rehabilitation. Each participant is studied under four conditions in a self-controlled design: baseline, post-manual therapy, post-functional therapy, and post-combined manual plus functional therapy, with a 7-day washout between sessions. Outcomes include gait analysis, range of motion, MAS, and gross motor function measures. The aim is to determine whether manual therapy primes the neuromotor system for subsequent rehabilitation to produce better short-term gait outcomes.

Why it matters

Potential benefit: If successful, patients could experience improved gait quality and motor control when manual therapy is used as a prep step before rehabilitation.

How similar studies have gone: Preliminary work in pediatric rehabilitation suggests that preparatory manual therapies can influence immediate gait parameters, but results are variable and require confirmation in CP.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of spastic Cerebral Palsy with lower limb involvement (hemiplegia or diplegia).
* Age between 12 months and 10 years.
* Gross Motor Function Classification System (GMFCS) level I, II, III, or IV.
* Modified Ashworth Scale (MAS) score ≤ 3 in the lower limbs.

Exclusion Criteria:

* Botulinum toxin injection in the lower limbs within the past 6 months.
* Prior functional orthopedic or neurosurgical procedures on the lower limbs.
* Concurrent participation in other experimental clinical studies involving the lower limbs.
* Cognitive impairment preventing comprehension of required motor tasks.

Where it's running

  • LIFE - Istituto Ricerca e Cura e Santa Lucia IRCCS
    Roma, Roma, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.